APO Research
Talk to an analyst

APO RESEARCH · REPORT

Self-replicating mRNA Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Self-replicating mRNA Vaccines Industry Growth and Trends Forecast to 2032

27 December 2025103 pages

Choose your research edition.

Industry ResearchSelf-replicating mRNA Vaccines Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Self-replicating mRNA Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Self-replicating mRNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Self-replicating mRNA Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Self-replicating mRNA Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Self-replicating mRNA Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Self-replicating mRNA Vaccines include Aldevron, Arcturus Therapeutics, BioNTech, Chimeron Bio, CSL, Elixirgen Therapeutics, Gritstone Bio, Precision Nanosystems and Replicate Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Self-replicating mRNA Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Self-replicating mRNA Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Self-replicating mRNA Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Self-replicating mRNA Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Self-replicating mRNA Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Self-replicating mRNA Vaccines Market by Company

Aldevron

Arcturus Therapeutics

BioNTech

Chimeron Bio

CSL

Elixirgen Therapeutics

Gritstone Bio

Precision Nanosystems

Replicate Bioscience

VaxEquity

Ziphius Vaccines

GSK

Immorna

Self-replicating mRNA Vaccines Segment by Type

Preventive Medicine

Medicine

Self-replicating mRNA Vaccines Segment by Application

Infectious Disease

Cancer

Others

Self-replicating mRNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self-replicating mRNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Self-replicating mRNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self-replicating mRNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Self-replicating mRNA Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Self-replicating mRNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Preventive Medicine Table 2. Major Company of Medicine Table 3. Global Self-replicating mRNA Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 5. Global Self-replicating mRNA Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Self-replicating mRNA Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Self-replicating mRNA Vaccines Price by Type (2021-2026) & (US$/Unit) Table 9. Global Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 10. Global Self-replicating mRNA Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Self-replicating mRNA Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Self-replicating mRNA Vaccines Price by Type (2027-2032) & (US$/Unit) Table 14. North America Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 15. North America Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 17. Europe Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 21. Latin America Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Self-replicating mRNA Vaccines Industry Trends Table 25. Self-replicating mRNA Vaccines Industry Drivers Table 26. Self-replicating mRNA Vaccines Industry Opportunities and Challenges Table 27. Self-replicating mRNA Vaccines Industry Restraints Table 28. Global Self-replicating mRNA Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Self-replicating mRNA Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Self-replicating mRNA Vaccines Sales by Company (2021-2026) & (K Units) Table 31. Global Self-replicating mRNA Vaccines Sales Share by Company (2021-2026) Table 32. Global Self-replicating mRNA Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Self-replicating mRNA Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Self-replicating mRNA Vaccines Major Company Production Sites and Headquarters Table 35. Global Self-replicating mRNA Vaccines Company, Product Type & Application Table 36. Global Self-replicating mRNA Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Self-replicating mRNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Self-replicating mRNA Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Self-replicating mRNA Vaccines Sales by Region (2021-2026) & (K Units) Table 41. Global Self-replicating mRNA Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Self-replicating mRNA Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Self-replicating mRNA Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Self-replicating mRNA Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Self-replicating mRNA Vaccines Sales by Region (2027-2032) & (K Units) Table 46. Global Self-replicating mRNA Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Self-replicating mRNA Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Self-replicating mRNA Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Self-replicating mRNA Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Self-replicating mRNA Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 52. Global Self-replicating mRNA Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Self-replicating mRNA Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Self-replicating mRNA Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 57. Global Self-replicating mRNA Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Self-replicating mRNA Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Self-replicating mRNA Vaccines Price by Application (2027-2032) & (US$/Unit) Table 61. North America Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 62. North America Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 64. Europe Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 68. Latin America Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Aldevron Company Information Table 72. Aldevron Business Overview Table 73. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Aldevron Self-replicating mRNA Vaccines Product Portfolio Table 75. Aldevron Recent Development Table 76. Arcturus Therapeutics Company Information Table 77. Arcturus Therapeutics Business Overview Table 78. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 80. Arcturus Therapeutics Recent Development Table 81. BioNTech Company Information Table 82. BioNTech Business Overview Table 83. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. BioNTech Self-replicating mRNA Vaccines Product Portfolio Table 85. BioNTech Recent Development Table 86. Chimeron Bio Company Information Table 87. Chimeron Bio Business Overview Table 88. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio Table 90. Chimeron Bio Recent Development Table 91. CSL Company Information Table 92. CSL Business Overview Table 93. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. CSL Self-replicating mRNA Vaccines Product Portfolio Table 95. CSL Recent Development Table 96. Elixirgen Therapeutics Company Information Table 97. Elixirgen Therapeutics Business Overview Table 98. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 100. Elixirgen Therapeutics Recent Development Table 101. Gritstone Bio Company Information Table 102. Gritstone Bio Business Overview Table 103. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio Table 105. Gritstone Bio Recent Development Table 106. Precision Nanosystems Company Information Table 107. Precision Nanosystems Business Overview Table 108. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio Table 110. Precision Nanosystems Recent Development Table 111. Replicate Bioscience Company Information Table 112. Replicate Bioscience Business Overview Table 113. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio Table 115. Replicate Bioscience Recent Development Table 116. VaxEquity Company Information Table 117. VaxEquity Business Overview Table 118. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. VaxEquity Self-replicating mRNA Vaccines Product Portfolio Table 120. VaxEquity Recent Development Table 121. Ziphius Vaccines Company Information Table 122. Ziphius Vaccines Business Overview Table 123. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio Table 125. Ziphius Vaccines Recent Development Table 126. GSK Company Information Table 127. GSK Business Overview Table 128. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. GSK Self-replicating mRNA Vaccines Product Portfolio Table 130. GSK Recent Development Table 131. Immorna Company Information Table 132. Immorna Business Overview Table 133. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Immorna Self-replicating mRNA Vaccines Product Portfolio Table 135. Immorna Recent Development Table 136. North America Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 138. North America Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2026) Table 139. North America Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Self-replicating mRNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. North America Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Self-replicating mRNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Self-replicating mRNA Vaccines Market Share by Country (2021-2026) Table 144. North America Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Self-replicating mRNA Vaccines Market Share Forecast by Country (2027-2032) Table 146. Europe Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 148. Europe Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2026) Table 149. Europe Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Self-replicating mRNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Self-replicating mRNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Self-replicating mRNA Vaccines Market Share by Country (2021-2026) Table 154. Europe Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Self-replicating mRNA Vaccines Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Self-replicating mRNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Self-replicating mRNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Self-replicating mRNA Vaccines Market Share by Country (2021-2026) Table 164. Asia-Pacific Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Self-replicating mRNA Vaccines Market Share Forecast by Country (2027-2032) Table 166. Latin America Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 168. Latin America Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2026) Table 169. Latin America Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Self-replicating mRNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Self-replicating mRNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Self-replicating mRNA Vaccines Market Share by Country (2021-2026) Table 174. Latin America Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Self-replicating mRNA Vaccines Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Self-replicating mRNA Vaccines Market Share by Country (2021-2026) Table 184. Middle East and Africa Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Self-replicating mRNA Vaccines Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Self-replicating mRNA Vaccines Distributors List Table 189. Self-replicating mRNA Vaccines Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Self-replicating mRNA Vaccines Image Figure 2. Global Self-replicating mRNA Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Self-replicating mRNA Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Self-replicating mRNA Vaccines Sales (2021-2032) & (K Units) Figure 5. Preventive Medicine Image Figure 6. Global Preventive Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Medicine Image Figure 8. Global Medicine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Self-replicating mRNA Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Self-replicating mRNA Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Self-replicating mRNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Self-replicating mRNA Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Self-replicating mRNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Self-replicating mRNA Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Self-replicating mRNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Self-replicating mRNA Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Self-replicating mRNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Self-replicating mRNA Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Self-replicating mRNA Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Infectious Disease Image Figure 24. Global Infectious Disease Sales YoY Growth (2021-2032) & (K Units) Figure 25. Cancer Image Figure 26. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Self-replicating mRNA Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Self-replicating mRNA Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Self-replicating mRNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Self-replicating mRNA Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Self-replicating mRNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Self-replicating mRNA Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Self-replicating mRNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Self-replicating mRNA Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Self-replicating mRNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Self-replicating mRNA Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Self-replicating mRNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Self-replicating mRNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Self-replicating mRNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Self-replicating mRNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Self-replicating mRNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Self-replicating mRNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Self-replicating mRNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Self-replicating mRNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Self-replicating mRNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Self-replicating mRNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Self-replicating mRNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Self-replicating mRNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Self-replicating mRNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Self-replicating mRNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Self-replicating mRNA Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Self-replicating mRNA Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Medicine
  • Medicine
Applications
  • Infectious Disease
  • Cancer
  • Others
Companies covered
  • Aldevron
  • Arcturus Therapeutics
  • BioNTech
  • Chimeron Bio
  • CSL
  • Elixirgen Therapeutics
  • Gritstone Bio
  • Precision Nanosystems
  • Replicate Bioscience
  • VaxEquity
  • Ziphius Vaccines
  • GSK
  • Immorna

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Self-replicating mRNA Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Self-replicating mRNA Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Self-replicating mRNA Vaccines Market by Type
  6. 1.3.1 Preventive Medicine
  7. 1.3.2 Medicine
  8. 1.4 Global Self-replicating mRNA Vaccines Market Size by Type
  9. 1.4.1 Global Self-replicating mRNA Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Self-replicating mRNA Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Self-replicating mRNA Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Self-replicating mRNA Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Self-replicating mRNA Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Self-replicating mRNA Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Self-replicating mRNA Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Self-replicating mRNA Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Self-replicating mRNA Vaccines Industry Trends
  2. 2.2 Self-replicating mRNA Vaccines Industry Drivers
  3. 2.3 Self-replicating mRNA Vaccines Industry Opportunities and Challenges
  4. 2.4 Self-replicating mRNA Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Self-replicating mRNA Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Self-replicating mRNA Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Self-replicating mRNA Vaccines Price (2021-2026)
  4. 3.4 Global Self-replicating mRNA Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Self-replicating mRNA Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Self-replicating mRNA Vaccines Company, Product Type & Application
  7. 3.7 Global Self-replicating mRNA Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Self-replicating mRNA Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Self-replicating mRNA Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Self-replicating mRNA Vaccines Tier 1, Tier 2, and Tier 3
4 Self-replicating mRNA Vaccines Regional Status and Outlook
  1. 4.1 Global Self-replicating mRNA Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Self-replicating mRNA Vaccines Historic Market Size by Region
  3. 4.2.1 Global Self-replicating mRNA Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Self-replicating mRNA Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Self-replicating mRNA Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Self-replicating mRNA Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Self-replicating mRNA Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Self-replicating mRNA Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Self-replicating mRNA Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Self-replicating mRNA Vaccines by Application
  1. 5.1 Self-replicating mRNA Vaccines Market by Application
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Self-replicating mRNA Vaccines Market Size by Application
  6. 5.2.1 Global Self-replicating mRNA Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Self-replicating mRNA Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Self-replicating mRNA Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Self-replicating mRNA Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Self-replicating mRNA Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Self-replicating mRNA Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Self-replicating mRNA Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Self-replicating mRNA Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Aldevron
  2. 6.1.1 Aldevron Company Information
  3. 6.1.2 Aldevron Business Overview
  4. 6.1.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Aldevron Self-replicating mRNA Vaccines Product Portfolio
  6. 6.1.5 Aldevron Recent Developments
  7. 6.2 Arcturus Therapeutics
  8. 6.2.1 Arcturus Therapeutics Company Information
  9. 6.2.2 Arcturus Therapeutics Business Overview
  10. 6.2.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  12. 6.2.5 Arcturus Therapeutics Recent Developments
  13. 6.3 BioNTech
  14. 6.3.1 BioNTech Company Information
  15. 6.3.2 BioNTech Business Overview
  16. 6.3.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BioNTech Self-replicating mRNA Vaccines Product Portfolio
  18. 6.3.5 BioNTech Recent Developments
  19. 6.4 Chimeron Bio
  20. 6.4.1 Chimeron Bio Company Information
  21. 6.4.2 Chimeron Bio Business Overview
  22. 6.4.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio
  24. 6.4.5 Chimeron Bio Recent Developments
  25. 6.5 CSL
  26. 6.5.1 CSL Company Information
  27. 6.5.2 CSL Business Overview
  28. 6.5.3 CSL Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CSL Self-replicating mRNA Vaccines Product Portfolio
  30. 6.5.5 CSL Recent Developments
  31. 6.6 Elixirgen Therapeutics
  32. 6.6.1 Elixirgen Therapeutics Company Information
  33. 6.6.2 Elixirgen Therapeutics Business Overview
  34. 6.6.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  36. 6.6.5 Elixirgen Therapeutics Recent Developments
  37. 6.7 Gritstone Bio
  38. 6.7.1 Gritstone Bio Company Information
  39. 6.7.2 Gritstone Bio Business Overview
  40. 6.7.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio
  42. 6.7.5 Gritstone Bio Recent Developments
  43. 6.8 Precision Nanosystems
  44. 6.8.1 Precision Nanosystems Company Information
  45. 6.8.2 Precision Nanosystems Business Overview
  46. 6.8.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio
  48. 6.8.5 Precision Nanosystems Recent Developments
  49. 6.9 Replicate Bioscience
  50. 6.9.1 Replicate Bioscience Company Information
  51. 6.9.2 Replicate Bioscience Business Overview
  52. 6.9.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio
  54. 6.9.5 Replicate Bioscience Recent Developments
  55. 6.10 VaxEquity
  56. 6.10.1 VaxEquity Company Information
  57. 6.10.2 VaxEquity Business Overview
  58. 6.10.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 VaxEquity Self-replicating mRNA Vaccines Product Portfolio
  60. 6.10.5 VaxEquity Recent Developments
  61. 6.11 Ziphius Vaccines
  62. 6.11.1 Ziphius Vaccines Company Information
  63. 6.11.2 Ziphius Vaccines Business Overview
  64. 6.11.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio
  66. 6.11.5 Ziphius Vaccines Recent Developments
  67. 6.12 GSK
  68. 6.12.1 GSK Company Information
  69. 6.12.2 GSK Business Overview
  70. 6.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GSK Self-replicating mRNA Vaccines Product Portfolio
  72. 6.12.5 GSK Recent Developments
  73. 6.13 Immorna
  74. 6.13.1 Immorna Company Information
  75. 6.13.2 Immorna Business Overview
  76. 6.13.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Immorna Self-replicating mRNA Vaccines Product Portfolio
  78. 6.13.5 Immorna Recent Developments
7 North America by Country
  1. 7.1 North America Self-replicating mRNA Vaccines Sales by Country
  2. 7.1.1 North America Self-replicating mRNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Self-replicating mRNA Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Self-replicating mRNA Vaccines Market Size by Country
  6. 7.2.1 North America Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Self-replicating mRNA Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Self-replicating mRNA Vaccines Sales by Country
  2. 8.1.1 Europe Self-replicating mRNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Self-replicating mRNA Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Self-replicating mRNA Vaccines Market Size by Country
  6. 8.2.1 Europe Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Self-replicating mRNA Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Self-replicating mRNA Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Self-replicating mRNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Self-replicating mRNA Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Self-replicating mRNA Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Self-replicating mRNA Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Self-replicating mRNA Vaccines Sales by Country
  2. 10.1.1 South America Self-replicating mRNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Self-replicating mRNA Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Self-replicating mRNA Vaccines Market Size by Country
  6. 10.2.1 South America Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Self-replicating mRNA Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Self-replicating mRNA Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Self-replicating mRNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Self-replicating mRNA Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Self-replicating mRNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Self-replicating mRNA Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Self-replicating mRNA Vaccines Value Chain Analysis
  2. 12.1.1 Self-replicating mRNA Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Self-replicating mRNA Vaccines Production Mode & Process
  7. 12.2 Self-replicating mRNA Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Self-replicating mRNA Vaccines Distributors
  10. 12.2.3 Self-replicating mRNA Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst